“New Thiadiazole Derivatives Show Promise as Anticancer Agents by Inhibiting VEGFR-2, Promoting Apoptosis, and Reducing Cancer Cell Migration”

https://pubmed.ncbi.nlm.nih.gov/38116168

New thiadiazole derivatives, including compound 14, show promising anti-cancer properties by inhibiting VEGFR-2, promoting apoptosis, and reducing cancer cell migration, highlighting their potential as leads for developing anticancer drugs.